{"id":"W4211142045","doi":"10.1016/j.kint.2018.12.025","title":"Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","year":2019,"lang":"en","type":"article","venue":"Kidney International","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"ca_institutions":"NOSM University; University of Toronto","funders":"Relypsa; Janssen Research and Development; National Institutes of Health; Akebia Therapeutics; Servier; Novo Nordisk; FibroGen; Bayer HealthCare; Sanofi; European Commission; National Institute of Diabetes and Digestive and Kidney Diseases; Amgen; Vifor Pharma; Pfizer; GlaxoSmithKline; Satellite Healthcare; Fresenius Medical Care North America; Celgene; AstraZeneca; Eli Lilly and Company","keywords":"Guideline; Kidney disease; Medicine; Intensive care medicine; Blood pressure; Dialysis; Multidisciplinary approach; Clinical Practice; Disease; Clinical trial; Internal medicine; Physical therapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07341785,0.001893126,0.002790435,0.004782415,0.002826006,0.009862076,0.00366241,0.01365454,0.007433936],"category_scores_gemma":[0.1155828,0.0007319905,0.005596118,0.004846941,0.003374885,0.009301498,0.00748125,0.02374042,0.002331819],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008975527,"about_ca_system_score_gemma":0.02174288,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00781393,"about_ca_topic_score_gemma":0.0114091,"domain_scores_codex":[0.9813328,0.009454419,0.002360926,0.001292591,0.004386253,0.001173081],"domain_scores_gemma":[0.9004811,0.06443797,0.00367789,0.001532206,0.023829,0.006041808],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004372757,0.00009445629,0.0006801988,0.004933139,0.0004794755,0.0001350124,0.0008002126,0.0001694582,0.0001309389,0.01355764,0.8605202,0.118062],"study_design_scores_gemma":[0.0003031128,0.0001012317,0.002657248,0.02910309,0.001009833,0.000153,0.001320367,0.0001458008,0.0001942404,0.02811456,0.9367878,0.0001098168],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0004021547,0.2206648,0.0003545988,0.7392967,0.0370473,0.00005424508,0.0003696998,0.00001866482,0.001791734],"genre_scores_gemma":[0.01437019,0.3447714,0.004461842,0.5482534,0.08365677,0.0004586128,0.001411113,0.0001113456,0.002505344],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.07341785,"threshold_uncertainty_score":0.3882753,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01341825457803769,"score_gpt":0.2721447551330451,"score_spread":0.2587265005550075,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}